As of 2025-07-14, the Relative Valuation of Terns Pharmaceuticals Inc (TERN) is (20.13) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.90 USD, the upside of Terns Pharmaceuticals Inc based on Relative Valuation is -510.8%.
The range of the Relative Valuation is (19.23) - (19.12) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.8x - 18.5x | 18.4x |
| Forward P/E multiples | 18.6x - 20.7x | 20.5x |
| Fair Price | (19.23) - (19.12) | (20.13) |
| Upside | -492.4% - -490.3% | -510.8% |
| Date | P/E |
| 2025-07-11 | -4.73 |
| 2025-07-10 | -4.71 |
| 2025-07-09 | -4.73 |
| 2025-07-08 | -4.38 |
| 2025-07-07 | -3.87 |
| 2025-07-03 | -4.17 |
| 2025-07-02 | -4.12 |
| 2025-07-01 | -3.72 |
| 2025-06-30 | -3.60 |
| 2025-06-27 | -3.70 |
| 2025-06-26 | -3.87 |
| 2025-06-25 | -3.92 |
| 2025-06-24 | -3.66 |
| 2025-06-23 | -3.56 |
| 2025-06-20 | -3.77 |
| 2025-06-18 | -3.87 |
| 2025-06-17 | -3.77 |
| 2025-06-16 | -3.87 |
| 2025-06-13 | -3.75 |
| 2025-06-12 | -3.80 |
| 2025-06-11 | -3.96 |
| 2025-06-10 | -3.92 |
| 2025-06-09 | -3.58 |
| 2025-06-06 | -3.58 |
| 2025-06-05 | -3.42 |
| 2025-06-04 | -3.39 |
| 2025-06-03 | -3.38 |
| 2025-06-02 | -3.17 |
| 2025-05-30 | -3.01 |
| 2025-05-29 | -3.00 |
| 2025-05-28 | -2.96 |
| 2025-05-27 | -2.91 |
| 2025-05-23 | -2.92 |
| 2025-05-22 | -2.84 |
| 2025-05-21 | -2.89 |
| 2025-05-20 | -3.04 |
| 2025-05-19 | -3.04 |
| 2025-05-16 | -2.78 |
| 2025-05-15 | -2.70 |
| 2025-05-14 | -2.69 |
| 2025-05-13 | -2.80 |
| 2025-05-12 | -2.92 |
| 2025-05-09 | -2.94 |
| 2025-05-08 | -2.90 |
| 2025-05-07 | -2.92 |
| 2025-05-06 | -2.91 |
| 2025-05-05 | -3.19 |
| 2025-05-02 | -3.38 |
| 2025-05-01 | -3.44 |
| 2025-04-30 | -3.19 |